• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.16% Nasdaq Up 0.25%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    6.11 Up 0.04(0.66%) 4:00PM EDT
    Add to Portfolio
    Prev Close:6.07
    Open:6.12
    Bid:5.75 x 200
    Ask:6.35 x 300
    1y Target Est:14.83
    Beta:2.16
    Earnings Date:Jul 27 - Jul 31 (Est.)
    Day's Range:5.97 - 6.20
    52wk Range:5.01 - 9.35
    Volume:381,737
    Avg Vol (3m):446,830
    Market Cap:256.19M
    P/E (ttm):N/A
    EPS (ttm):-0.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ECYT

    Comparison

    Symbol% ChgMkt Cap
    ECYTUp 0.66%256.19M
    NKTRDown 0.17%1.51B
    RHHBYDown 3.80%N/A
    SNSS 0.00%172.92M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.23
    Quarterly EPS Est (Jun-15) :-0.29
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback